Publication | Closed Access

The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study

Retrospective Cohort StudyGastrointestinal OncologyMedicineCancer ManagementGastroenterologyGynecologyRecurrent Ovarian CancerSurgeryCancer TreatmentOncologyGynecology OncologyOvarian Cancer